Novartis investigative site

Padova 35128

0 studies enrolling now · 12 studies all time

What they study most

Alzheimer Disease, Chronic Myeloid Leukemia, Cryopyrin-Associated Periodic Syndromes, Fallopian Tube Cancer, Familial Cold Autoinflammatory Syndrome, Fragile X Syndrome, Kidney Transplantation, Muckle Wells Syndrome, Multiple Sclerosis, Neonatal Onset Multisystem Inflammatory Disease, Neoplasms, Breast, Non-radiographic Spondyloarthritis

Studies at this site

Study of Efficacy and Safety of Secukinumab in Patients With Non-radiographic Axial Spondyloarthritis — Completed
24 Month Extension to Efficacy and Safety of AEB071 Plus Tacrolimus (Converted to Mycophenolic Acid After 3 Months) in Renal Transplant Patients(Converted to Mycophenolic Acid After 3 Months) in Renal Transplant Patients — Stopped early
Patupilone Versus Doxorubicin in Patients With Ovarian, Primary Fallopian, or Peritoneal Cancer — Completed
Optical Coherence Tomography (OCT) Trial in Multiple Sclerosis — Completed
Single-dose Study to Assess Efficacy of Canakinumab (ACZ885) in Patients With Active Juvenile Idiopathic Arthritis (SJIA) — Stopped early
Efficacy and Safety of ACZ885 in Patients With the Following Cryopyrin-associated Periodic Syndromes: Familial Cold Autoinflammatory Syndrome, Muckle-Wells Syndrome, or Neonatal Onset Multisystem Inflammatory Disease — Completed
EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer — APPROVED_FOR_MARKETING
Long-term, Safety and Tolerability Study of AFQ056 in Adolescent Patients With Fragile X Syndrome (Open-label) — Stopped early
Safety and Efficacy of AFQ056 in Adolescent Patients With Fragile X Syndrome — Completed
Flare Prevention Study of Canakinumab in Patients With Active Systemic Juvenile Idiopathic Arthritis (SJIA) — Completed
Comparative Efficacy, Safety, and Tolerability of Rivastigmine 10 and 15 cm^2 Patch in Patients With Alzheimer's Disease (AD) Showing Cognitive Decline — Completed
Expanded Access Program of AMN107 in Imatinib-resistant or Intolerant Adult Patients With Chronic Myeloid Leukemia — NO_LONGER_AVAILABLE